NEKTAR THERAPEUTICS Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Nektar Therapeutics quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Nektar Therapeutics Other Assets, Noncurrent for the quarter ending June 30, 2024 was $4.31M, a 161% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.31M +$2.66M +161% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $4.66M +$3.25M +231% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $4.64M +$2.4M +107% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $4.52M +$2.2M +94.7% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.65M -$582K -26.1% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.41M -$115K -7.56% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $2.25M -$499K -18.2% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $2.32M +$479K +26% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $2.23M +$1.89M +549% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $1.52M +$86K +5.99% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $2.74M +$1.28M +87.8% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.84M +$424K +29.9% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $344K -$1.07M -75.7% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $1.44M Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $1.46M +$1.12M +325% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.42M -$965K -40.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $1.41M -$987K -41.1% Jun 30, 2020 10-Q 2020-08-07
Q4 2019 $344K -$3.9M -91.9% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $2.39M -$1.01M -29.7% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.4M -$962K -28.6% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $2.37M +$1.58M +200% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $4.24M +$3.25M +327% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $3.39M +$2.63M +343% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $3.36M +$2.26M +205% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $789K -$76K -8.79% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $994K +$177K +21.7% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $767K +$248K +47.8% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $1.1M +$600K +119% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $865K +$184K +27% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $817K +$63K +8.36% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $519K -$13.3M -96.3% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $504K -$5.26M -91.3% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $681K -$5.47M -88.9% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $754K -$5.8M -88.5% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $13.9M +$6.86M +97.9% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $5.76M -$1.58M -21.5% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $6.15M -$1.62M -20.9% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 $6.55M -$1.62M -19.8% Dec 31, 2014 10-K 2016-03-01
Q3 2014 $7.01M -$1.5M -17.7% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $7.34M -$1.69M -18.7% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $7.77M -$1.48M -16% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $8.17M -$1.27M -13.5% Dec 31, 2013 10-K 2015-02-26
Q3 2013 $8.51M -$1.22M -12.5% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $9.04M +$3.34M +58.7% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $9.25M +$3.91M +73.1% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $9.44M +$8.44M +845% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $9.73M +$8.88M +1051% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $5.69M +$4.76M +508% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $5.35M +$4.37M +448% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $999K +$27K +2.78% Dec 31, 2011 10-K 2013-03-01
Q3 2011 $845K Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $936K Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $976K Mar 31, 2011 10-Q 2011-04-29
Q4 2010 $972K Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.